90% of drugs fail in clinical trials. In this session, Renata Crome (former Roche) discusses how emerging biotechs and charities can bridge the credibility gap and build a strategic roadmap for successful licensing and market launch.
View details
Contributors:Ajay Karandikar, Founder & CEO, OmnitheiaRenata Crome, Advisory Board, Omnitheia (Former Deputy Global Head, Roche) Reading Time: 6 minutes The Clinical Attrition Reality The pharmaceutical industry is currently defined by a significant paradox. While the average cost to develop a single drug has soared to $2.3 billion, the probability of success remains alarmingly low. Nine…
View details